| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Program in Neuroscience (M.D.M.), Department of Cell Biology, Neurobiology, and Anatomy (L.L.D.C.), Stritch School of Medicine, Loyola University Chicago, Maywood, Illinois 60153
Address all correspondence and requests for reprints to: Lydia L. DonCarlos, 2160 South First Avenue, Stritch School of Medicine, Loyola University Chicago, Maywood, Illinois 60153. E-mail: ldoncar{at}luc.edu
Testosterone is the principal gonadal hormone responsible for the masculinization of the rat nervous system. Sex differences in both the ligand and receptor availability may play a role in the process of sexual differentiation. In some brain regions, males express more androgen receptor (AR) messenger RNA (mRNA) than females by postnatal day (PND) 10. Gonadectomy on the day of birth (PND-0) eliminated the sex differences in AR mRNA expression at PND-10, and exogenous testosterone replacement restored this sex difference. Because testosterone can be converted to both androgenic and estrogenic metabolites in the brain, the present experiments were performed to determine whether androgenic or estrogenic metabolites of testosterone are responsible for region-specific regulation of AR mRNA content in the developing rat forebrain. We used a 35S-labeled riboprobe and in situ hybridization to assess relative steady-state levels of AR mRNA in animals killed on PND-10. In the principal portion of the bed nucleus of the stria terminalis (BSTpr) and medial preoptic area (MPO), males gonadectomized on PND-0 and treated daily with dihydrotestosterone propionate (DHTP), a nonaromatizable androgen, had low levels of AR mRNA that were not significantly different from AR mRNA levels in intact females. In contrast, males gonadectomized on PND-0 and treated daily with diethylstilbestrol (DES), a synthetic estrogen, maintained high, male-typical levels of AR mRNA in the BSTpr and the MPO. AR mRNA content in the VMH was not sexually differentiated in PND-10 rats and was unaffected by gonadectomy or hormone replacement. To further assess whether AR mRNA was autologously regulated, neonatal male rats were treated with the androgen receptor antagonist, flutamide. Flutamide at a dose of either 40 µg/day or 300 µg/day had no effect on AR mRNA expression in any area examined. Thus, AR mRNA is up-regulated by estrogen but is not regulated by androgen during the early postnatal period.
This article has been cited by other articles:
![]() |
C A Wilson and D C Davies The control of sexual differentiation of the reproductive system and brain Reproduction, February 1, 2007; 133(2): 331 - 359. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Lonstein, B. D. Rood, and G. J. De Vries Unexpected Effects of Perinatal Gonadal Hormone Manipulations on Sexual Differentiation of the Extrahypothalamic Arginine-Vasopressin System in Prairie Voles Endocrinology, March 1, 2005; 146(3): 1559 - 1567. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Dietrich, A. Haitel, J. C. Huber, and W. J. Reiter Expression of Estrogen Receptors in Human Corpus Cavernosum and Male Urethra J. Histochem. Cytochem., March 1, 2004; 52(3): 355 - 360. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Azad, S. Pitale, W. E. Barnes, and N. Friedman Testosterone Treatment Enhances Regional Brain Perfusion in Hypogonadal Men J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3064 - 3068. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Jesmin, C. N. Mowa, N. Matsuda, A.-E. Salah-Eldin, H. Togashi, I. Sakuma, Y. Hattori, and A. Kitabatake Evidence for a Potential Role of Estrogen in the Penis: Detection of Estrogen Receptor-{alpha} and -{beta} Messenger Ribonucleic Acid and Protein Endocrinology, December 1, 2002; 143(12): 4764 - 4774. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Weihua, J. Ekman, A. Almkvist, S. Saji, L. Wang, M. Warner, and J.-A. Gustafsson Involvement of Androgen Receptor in 17{beta}-Estradiol-Induced Cell Proliferation in Rat Uterus Biol Reprod, August 1, 2002; 67(2): 616 - 623. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. Hsing, Y.-T. Gao, G. Wu, X. Wang, J. Deng, Y.-L. Chen, I. A. Sesterhenn, F. K. Mostofi, J. Benichou, and C. Chang Polymorphic CAG and GGN Repeat Lengths in the Androgen Receptor Gene and Prostate Cancer Risk: A Population-based Case-Control Study in China Cancer Res., September 1, 2000; 60(18): 5111 - 5116. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |